Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Angina with non-obstructive coronary arteries and myocardial bridge: long-term outcomes of surgical unroofing.

European heart journal·2026

Same author

Validation of biomarker-based stratification for risk of long-term outcomes after acute kidney injury.

Clinical kidney journal·2026

Same author

Trauma Preconditioning of Cytokine Response: Comparison of Perioperative Cytokine Profiles in Elective Cardiac versus Orthopaedic Trauma Surgery Patients.

International journal of nephrology and renovascular disease·2026

Same author

Simultaneous detection of thyroid-stimulating hormone and C-reactive protein using a multiplex lateral flow device for improved hypothyroidism diagnosis.

RSC advances·2026

Same author

Prevalence of polypharmacy and associated side effects in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis.

BMJ nutrition, prevention & health·2026

Same author

Case Report: Elevated Lp(a) as a cause of severe ASCVD in a healthy veteran athlete with low calculated QRISK3 score.

Frontiers in cardiovascular medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System

An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System

Published on: March 17, 2023

Development of pediatric wait time access targets.

James G Wright¹, Kayi Li, Cathy Seguin

¹Department of Surgery, Robert B. Salter Chair of Pediatric Surgical Research, The Hospital for Sick Children, Toronto, Ont., Canada. james.wright@sickkids.ca

Canadian Journal of Surgery. Journal Canadien De Chirurgie

|March 30, 2011

Summary

This summary is machine-generated.

Developing pediatric surgical wait time targets is crucial for Canadian children. This study established standardized access targets for pediatric surgical care, improving timely consultations and surgeries.

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Experiment Videos

Last Updated: Jun 3, 2026

An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System

An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System

Published on: March 17, 2023

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Area of Science:

Pediatric Surgery
Health Services Research
Healthcare Management

Background:

Effective wait time management is a national priority in Canada.
Existing research primarily addresses adult surgical wait times.
Pediatric surgical wait times require specific attention and targets.

Purpose of the Study:

To develop evidence-based surgical wait time access targets for pediatric patients.
To address the gap in research focused on children's surgical wait times.
To create a standardized framework for pediatric surgical care access.

Main Methods:

Utilized nominal group techniques with expert panels.
Achieved consensus on prioritization levels for 574 diagnoses across 10 surgical disciplines.
Defined targets for wait 1 (consultation) and wait 2 (surgery).

Main Results:

Established a 7-stage priority classification system for pediatric surgical care.
Defined permissible timeframes for consultations (W1) and surgeries (W2).
Linked access targets to 574 specific diagnoses within 10 pediatric surgical subspecialties.

Conclusions:

The developed targets offer a standardized, comprehensive, and consensus-driven model for Canadian children's hospitals.
This model provides a systematic approach to managing pediatric surgical wait times.
Future research will evaluate the impact of these targets on improving access to pediatric surgical care.